GBI Research Market Research Reports

Title published price

Renal Cluster Drug Development Pipeline Review, 2017

By GBI Research

Renal Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key play ...

11-May-2017 $3995

Women's Health Cluster Drug Development Pipeline Review, 2017

By GBI Research

Women's Health Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the women's health pipeline landscape. The report provides comprehensive information on the therapeutics under development an ...

10-May-2017 $3995

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017

By GBI Research

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017 Summary This report provides an overview of the toxicology pipeline landscape. The report provides comprehensive information on the therapeutic ...

09-May-2017 $3995

CNS Cluster Addiction Drug Development Pipeline Review, 2017

By GBI Research

CNS Cluster Addiction Drug Development Pipeline Review, 2017 Summary This report provides an overview of the CNS Clusters pipeline landscape. The report provides comprehensive information on the therapeutics under development, and ...

08-May-2017 $3995

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017

By GBI Research

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 Summary This report provides an overview of the genetic disorders pipeline landscape. The report provides comprehensive information on the therapeut ...

08-May-2017 $3995

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

By GBI Research

Rheumatoid arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. It is characterized by synovial inflammation and gradual bone erosion over many years (Lefèvre et al., 2009). ...

01-Apr-2017 $4995

Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

By GBI Research

Breast cancer is a malignant neoplasm that begins in the breast tissue, which is made up of glands for milk production called lobules and the ducts that connect the lobules to the nipples. Most breast cancers are invasive cancers that have grown b ...

01-Apr-2017 $4995

Antibacterial Therapies Drug Development Pipeline Review, 2017

By GBI Research

The antibacterial drug market covers the drugs used in the prophylaxis and treatment of bacterial infections. With a growing global concern over antimicrobial resistance and its progressive growth, there is a pronounced need for innovation within ...

22-Mar-2017 $3995

Neurodegenerative Disorders Drug Development Pipeline Review, 2017

By GBI Research

Neurodegenerative disorders are a cluster of conditions that affect the central nervous system. They include both hereditary and sporadic conditions that are characterized by slow, irreversible, progressive dysfunction of the nervous system with t ...

21-Mar-2017 $3995

Cardiovascular Disorders Drug Development Pipeline Review, 2017

By GBI Research

Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia of which accelerate the development of atherosclero ...

16-Mar-2017 $3995

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

By GBI Research

Many countries are facing the challenge of an aging population, and there will be an increased number of people aged 60 and over - a high-risk age range for lung cancer. Over half of the incident cases of non-small cell lung cancer (NSCLC) are dia ...

09-Mar-2017 $4995

Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products

By GBI Research

Summary Fatty liver disease (FLD) comprises a spectrum of chronic liver disorders characterized by excessive lipid accumulation in the liver (steatosis), which may lead to inflammation (steatohepatitis) and fibrosis. It ha ...

02-Mar-2017 $6995

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

By GBI Research

Summary Cancer is a disease characterized by abnormal cell growth and uncontrolled proliferation caused by a series of mutations that result in the formation of tumor, which can migrate around the body, in a process known ...

01-Mar-2017 $4995

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

By GBI Research

Respiratory complications are a diverse set of indications that include respiratory disorders, cardiovascular disorders and infectious diseases. They are therefore associated with a broad range of underlying pathophysiology, which is reflected in ...

01-Mar-2017 $4995

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation

By GBI Research

Head and neck cancer (HNC) is the sixth most common malignancy worldwide, and its incidence is rising (Lacko et al., 2014). It represents a number of cancers that are known collectively as HNCs, and which usually begin in the squamous cells that l ...

01-Mar-2017 $6995

Colorectal Cancer - Heat Map and Analysis

By GBI Research

Summary Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It ...

01-Feb-2017 $2000

Parkinson's Disease - Heat Map and Analysis

By GBI Research

Summary Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairme ...

09-Jan-2017 $2000

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

By GBI Research

Bacteria are a major class of prokaryotic micro-organism and are broadly classified as either gram-positive bacteria, which retain their color under gram-staining and have an inner plasma membrane and a thick peptidoglycan layer, or gram-negative ...

09-Jan-2017 $4995

Non-Hodgkin Lymphoma - Heat Map and Analysis

By GBI Research

Summary Non-Hodgkin lymphomas (NHL) are a heterogeneous group of malignancies that originate from lymphoid tissue, with varied clinical and biological features. There were an estimated 385,741 new cases of NHL and 199,630 ...

06-Jan-2017 $2000

Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential

By GBI Research

Immunology is one of the largest therapy areas, with a total of 2,145 products in active development, trailing only oncology, infectious diseases and central nervous system disorders in terms of pipeline size. There are a total of 539 immunology p ...

05-Jan-2017 $6995